Axsome Therapeutics Inc (AXSM)
SG&A Expense Growth
12.51%
Quarterly · Period ending:
AXSM SG&A Expense Growth
Latest reported12.51%period ending
Latest reported12.51%period ending
AXSM Quarterly SG&A Growth (QoQ) (0.00% → 12.51%)
Latest values, visible window
High-resolution chart · PNG
AXSM sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 12.5089% | |
| 9.2731% | |
| 12.6881% | |
| 15.317% | |
| 7.8593% | |
| 6.6354% | |
| 18.5289% | |
| -7.7158% | |
| 4.6317% | |
| 14.0089% | |
| 4.3528% | |
| 5.388% | |
| 6.3943% | |
| 20.641% | |
| 50.3897% | |
| 31.2323% | |
| 21.2263% | |
| 36.5303% | |
| -6.9229% | |
| 23.7545% | |
| 45.3042% | |
| 8.5802% | |
| 63.6235% | |
| -12.5012% | |
| 45.5894% | |
| -4.841% | |
| 67.8492% | |
| 27.2623% | |
| -13.2457% | |
| 22.5877% | |
| 4.3767% | |
| -9.6915% | |
| 1.1765% | |
| 23.6123% | |
| 6.7853% | |
| 4.7559% | |
| 3.3532% | |
| -7.2562% | |
| 10.9677% | |
| 7.1805% | |
| 12.7234% | |
| 43.3116% | |
| 89.5431% | |
| 9.4238% | |
| -11.6922% | |
| -13.98% | |
| 52.0302% | |
| 99.2061% | |
| 0% | |
| 0% |